We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgery Better Than Muscle Training for Urinary Incontinence

By HospiMedica International staff writers
Posted on 30 Sep 2013
A new study shows that women with stress urinary incontinence (SUI) had better subjective improvement and higher cure rates when treated initially with surgery instead of pelvic floor-muscle training.

Researchers at University Medical Center Utrecht (The Netherlands) and 23 other participating centers conducted a multicenter, randomized trial to compare physiotherapy involving pelvic-floor muscle training—advocated as first-line treatment for SUI—and midurethral-sling surgery (generally recommended when physiotherapy is unsuccessful). More...
In all, 230 women were assigned to each group, and crossover between groups was allowed. The primary outcome was subjective improvement, measured by means of the Patient Global Impression of Improvement (PGII) at 12 months.

The results showed that PGII improvement was reported by 90.8% of women in the surgery group and 64.4% of women in the physiotherapy group, while rates of objective cure were 76.5% and 58.8%, respectively. In all, 49% of women in the physiotherapy group and 11.2% of women in the surgery group crossed over to the alternative treatment. Women who crossed over to the surgery group had outcomes similar to those of women initially assigned to surgery, and both these groups had outcomes superior to those of women who did not cross over to surgery. The study was published online on September 18, 2013, in the New England Journal of Medicine (NEJM).

“Our findings suggest that women with [SUI] should be counseled regarding both pelvic floor-muscle training and midurethral-sling surgery as initial treatment options,” concluded lead author Julien Labrie, MD, and colleagues. “Information on expected outcomes with both interventions, as well as on the potential, albeit infrequent, complications of surgery, will allow for individualized decision making by each women and her healthcare provider.”

There are various surgical options for women with SUI who have not responded to physiotherapy or medications. The mid-urethral sling is a piece of surgical tape that supports the middle section of the urethra, and is intended for women with SUI whose muscles and nerves in this area are no longer working properly. The procedure is sometimes performed in combination with other procedures, such as vaginal repair.

Related Links:
University Medical Center Utrecht



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.